Serina Therapeutics Inc (SER)

$5.18 +0.09 (1.77%)
Market Cap 52.18M
Revenue (ttm) 60,000.00
Net Income (ttm) -11.14M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -18,566.67%
Debt to Equity Ratio 0.00
Volume 62,120
Avg Vol 148,274
Day's Range N/A - N/A
Shares Out 10.25M
Stochastic %K 12%
Beta 0.76
Analysts Strong Sell
Price Target $13.00

Company Profile

Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson's disease that is in preclinical stage development; and POZ-lipids, a non-immunogenic alternative to the PEG-lipids in the lipid nanoparticles. The company also develops SER 214 a POZ conjugate of rotigotine for the treatment of early Parkinson's and Restless Leg Syndrome, which...

Industry: Biotechnology
Sector: Healthcare
Phone: 256 327 9630
Address:
601 Genome Way, Suite 2001, Huntsville, United States
titotito25
titotito25 Sep. 5 at 6:29 PM
$SER look at the chart it will be above 6 .5 sooner than later
0 · Reply
titotito25
titotito25 Sep. 4 at 9:51 AM
$SER
0 · Reply
Bullliissh
Bullliissh Sep. 3 at 6:57 PM
$SER
0 · Reply
StockBroker101
StockBroker101 Sep. 2 at 2:35 PM
$NVDA This is going to boom up $SER My new favorite stock THIS STOCK IS READY TO EXPLODE UP if your looking for some massive gains today $SER to the moon opportunity waiting for you . Your welcome!!!
0 · Reply
titotito25
titotito25 Aug. 29 at 7:11 PM
$SER
0 · Reply
StockBroker101
StockBroker101 Aug. 29 at 2:14 PM
$OPEN $OPAD $SER $SER dont miss out on this one
0 · Reply
StockBroker101
StockBroker101 Aug. 29 at 2:07 PM
$PMI Here we go baby! $SER check this one out
0 · Reply
BioTechHealthX
BioTechHealthX Aug. 29 at 1:57 AM
$SER Analysts see Serina stock surging as its unique POZ technology delivers long-acting therapies for neurological diseases with huge unmet need. https://biotechhealthx.com/biotech-news/wall-street-predicts-130-upside-for-serina-therapeutics-ser/
0 · Reply
wsb_kenny
wsb_kenny Aug. 28 at 7:13 PM
$SER it's time for run back to $8.8
1 · Reply
titotito25
titotito25 Aug. 28 at 6:57 PM
$SER volume low need wome volume to move up
0 · Reply
Latest News on SER
Serina Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Sep 8, 2025, 6:00 AM EDT - 10 hours ago

Serina Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Serina Therapeutics Announces FDA Feedback Supports Registrational Trial Design of SER-252 in Advanced Parkinson's Disease under 505(b)(2) NDA Pathway

Aug 25, 2025, 4:15 PM EDT - 14 days ago

Serina Therapeutics Announces FDA Feedback Supports Registrational Trial Design of SER-252 in Advanced Parkinson's Disease under 505(b)(2) NDA Pathway

Serina Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights

Aug 11, 2025, 4:30 PM EDT - 4 weeks ago

Serina Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights

Serina Therapeutics Advances POZ-VMAT2i into Development for Tardive Dyskinesia (TD)

Jul 29, 2025, 6:44 AM EDT - 5 weeks ago

Serina Therapeutics Advances POZ-VMAT2i into Development for Tardive Dyskinesia (TD)

Serina Therapeutics to Present at the BTIG Virtual Biotechnology Conference

Jul 28, 2025, 6:00 AM EDT - 6 weeks ago

Serina Therapeutics to Present at the BTIG Virtual Biotechnology Conference

Serina Therapeutics Makes Grant to New Employee Under Inducement Plan

Jul 10, 2025, 4:10 PM EDT - 2 months ago

Serina Therapeutics Makes Grant to New Employee Under Inducement Plan

Serina Therapeutics Announces Date for 2025 Annual Stockholders Meeting

Jul 1, 2025, 4:15 PM EDT - 2 months ago

Serina Therapeutics Announces Date for 2025 Annual Stockholders Meeting

Serina Therapeutics to Present at FORCE Family Office Investor Webinar on June 26, 2025

Jun 23, 2025, 7:24 PM EDT - 2 months ago

Serina Therapeutics to Present at FORCE Family Office Investor Webinar on June 26, 2025

UPDATED: Serina Therapeutics Congratulates Juvenescence Ltd. on $76M First Tranche Close of Series B Funding and Strategic Partnership with M42

Jun 17, 2025, 8:30 PM EDT - 2 months ago

UPDATED: Serina Therapeutics Congratulates Juvenescence Ltd. on $76M First Tranche Close of Series B Funding and Strategic Partnership with M42

Serina Therapeutics Congratulates Juvenescence Ltd. on $150M Series B Funding and Strategic Partnership with M42

Jun 17, 2025, 6:00 AM EDT - 2 months ago

Serina Therapeutics Congratulates Juvenescence Ltd. on $150M Series B Funding and Strategic Partnership with M42

Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event "Is the Beaten Down Biotech Sector the Smartest Bet in Today's Volatile Market?"

Jun 9, 2025, 4:05 PM EDT - 3 months ago

Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event "Is the Beaten Down Biotech Sector the Smartest Bet in Today's Volatile Market?"

Serina Therapeutics Appoints Stephen Brannan, M.D. to Board of Directors

May 22, 2025, 4:50 PM EDT - 3 months ago

Serina Therapeutics Appoints Stephen Brannan, M.D. to Board of Directors

Serina Therapeutics Makes Grants to New Employees Under Inducement Plan

May 14, 2025, 3:15 PM EDT - 4 months ago

Serina Therapeutics Makes Grants to New Employees Under Inducement Plan

Serina Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights

May 8, 2025, 4:23 PM EDT - 4 months ago

Serina Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights

Serina Therapeutics to Present at JonesResearch Virtual CNS Day

Apr 29, 2025, 6:00 AM EDT - 4 months ago

Serina Therapeutics to Present at JonesResearch Virtual CNS Day

Serina Therapeutics to Present at the 4th LNP Formulation & Process Development Summit

Apr 15, 2025, 6:30 AM EDT - 5 months ago

Serina Therapeutics to Present at the 4th LNP Formulation & Process Development Summit

Serina Therapeutics Secures $5 Million in Funding to Support Advancement of SER-252 into Clinical Development in Advanced Parkinson's Disease

Apr 8, 2025, 4:30 PM EDT - 5 months ago

Serina Therapeutics Secures $5 Million in Funding to Support Advancement of SER-252 into Clinical Development in Advanced Parkinson's Disease

Serina Therapeutics to Present at the Jones Healthcare and Technology Innovation Conference

Apr 7, 2025, 6:30 AM EDT - 5 months ago

Serina Therapeutics to Present at the Jones Healthcare and Technology Innovation Conference

Serina Therapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights

Mar 24, 2025, 4:30 PM EDT - 6 months ago

Serina Therapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights

Serina Therapeutics to Present at the American Chemistry Society (ACS) Spring 2025 Meeting

Mar 24, 2025, 6:30 AM EDT - 6 months ago

Serina Therapeutics to Present at the American Chemistry Society (ACS) Spring 2025 Meeting

Serina Therapeutics Appoints Dr. Jay Venkatesan to its Board of Directors

Feb 12, 2025, 4:15 PM EST - 7 months ago

Serina Therapeutics Appoints Dr. Jay Venkatesan to its Board of Directors

Serina Therapeutics Receives Second $5 Million Tranche to Strengthen Cash Position Ahead of Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients

Feb 3, 2025, 4:30 PM EST - 7 months ago

Serina Therapeutics Receives Second $5 Million Tranche to Strengthen Cash Position Ahead of Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients

Serina Therapeutics Announces Sale of UniverXome Subsidiary

Jan 15, 2025, 4:05 PM EST - 8 months ago

Serina Therapeutics Announces Sale of UniverXome Subsidiary

Serina Therapeutics Welcomes Karen J. Wilson to its Board of Directors

Jan 14, 2025, 5:25 PM EST - 8 months ago

Serina Therapeutics Welcomes Karen J. Wilson to its Board of Directors

Serina Therapeutics to Present at Tribe Public's Webinar Event "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond" on Wednesday, December 18, 2024

Dec 16, 2024, 6:00 AM EST - 9 months ago

Serina Therapeutics to Present at Tribe Public's Webinar Event "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond" on Wednesday, December 18, 2024

Serina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity Summit

Dec 11, 2024, 6:05 AM EST - 9 months ago

Serina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity Summit

Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate into Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients

Dec 2, 2024, 5:22 PM EST - 9 months ago

Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate into Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients

Serina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights

Nov 12, 2024, 5:00 PM EST - 10 months ago

Serina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights

Serina Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 4, 2024, 6:42 PM EDT - 1 year ago

Serina Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Serina Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights

Aug 9, 2024, 4:15 PM EDT - 1 year ago

Serina Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights

Serina Therapeutics to Present Novel Data on POZ-Lipid Technology Potentially Enhancing Safety and Efficacy of mRNA LNP Formulations at the 4th mRNA-Based Therapeutics Summit

Jul 29, 2024, 8:30 AM EDT - 1 year ago

Serina Therapeutics to Present Novel Data on POZ-Lipid Technology Potentially Enhancing Safety and Efficacy of mRNA LNP Formulations at the 4th mRNA-Based Therapeutics Summit

Serina Therapeutics Appoints Srini Tenjarla, Ph.D. as Senior Vice President of CMC and Formulation

Jul 18, 2024, 5:00 PM EDT - 1 year ago

Serina Therapeutics Appoints Srini Tenjarla, Ph.D. as Senior Vice President of CMC and Formulation

Serina Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights

May 14, 2024, 4:05 PM EDT - 1 year ago

Serina Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights

Serina Therapeutics Appoints Dr. Simba Gill as Executive Chairman

Apr 17, 2024, 4:05 PM EDT - 1 year ago

Serina Therapeutics Appoints Dr. Simba Gill as Executive Chairman

Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics

Mar 26, 2024, 5:04 PM EDT - 1 year ago

Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics

AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results

Mar 22, 2024, 5:27 PM EDT - 1 year ago

AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results

AGEX THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AgeX Therapeutics, Inc. - AGE

Feb 27, 2024, 3:19 PM EST - 1 year ago

AGEX THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AgeX Therapeutics, Inc. - AGE

AgeX Therapeutics Reports Third Quarter 2023 Financial Results

Nov 14, 2023, 4:05 PM EST - 1 year ago

AgeX Therapeutics Reports Third Quarter 2023 Financial Results

Serina Therapeutics and AgeX Therapeutics Enter into Merger Agreement

Aug 30, 2023, 7:00 AM EDT - 2 years ago

Serina Therapeutics and AgeX Therapeutics Enter into Merger Agreement

AgeX Therapeutics Reports Second Quarter 2023 Financial Results

Aug 14, 2023, 4:05 PM EDT - 2 years ago

AgeX Therapeutics Reports Second Quarter 2023 Financial Results

AgeX Therapeutics Closes $36,000,000 Debt Exchange for Preferred Stock

Jul 24, 2023, 6:28 PM EDT - 2 years ago

AgeX Therapeutics Closes $36,000,000 Debt Exchange for Preferred Stock

AgeX Therapeutics Announces $36,000,000 Debt Exchange for Preferred Stock

Jul 21, 2023, 5:32 PM EDT - 2 years ago

AgeX Therapeutics Announces $36,000,000 Debt Exchange for Preferred Stock

AgeX Therapeutics Announces Appeal of NYSE American Determination

May 23, 2023, 4:05 PM EDT - 2 years ago

AgeX Therapeutics Announces Appeal of NYSE American Determination

CORRECTING and REPLACING NYSE American to Commence Delisting Proceedings Against AgeX Therapeutics, Inc. (AGE)

May 17, 2023, 5:31 PM EDT - 2 years ago

CORRECTING and REPLACING NYSE American to Commence Delisting Proceedings Against AgeX Therapeutics, Inc. (AGE)

NYSE American to Suspend Trading Immediately in AgeX Therapeutics, Inc. (AGE) and Commence Delisting Proceedings

May 17, 2023, 4:34 PM EDT - 2 years ago

NYSE American to Suspend Trading Immediately in AgeX Therapeutics, Inc. (AGE) and Commence Delisting Proceedings

AgeX Therapeutics Reports First Quarter 2023 Financial Results

May 12, 2023, 4:05 PM EDT - 2 years ago

AgeX Therapeutics Reports First Quarter 2023 Financial Results

AgeX Therapeutics Receives Stock Exchange Deficiency Letter

Apr 26, 2023, 4:05 PM EDT - 2 years ago

AgeX Therapeutics Receives Stock Exchange Deficiency Letter

AgeX Therapeutics Reports Fourth Quarter and Annual 2022 Financial Results

Mar 31, 2023, 4:05 PM EDT - 2 years ago

AgeX Therapeutics Reports Fourth Quarter and Annual 2022 Financial Results

titotito25
titotito25 Sep. 5 at 6:29 PM
$SER look at the chart it will be above 6 .5 sooner than later
0 · Reply
titotito25
titotito25 Sep. 4 at 9:51 AM
$SER
0 · Reply
Bullliissh
Bullliissh Sep. 3 at 6:57 PM
$SER
0 · Reply
StockBroker101
StockBroker101 Sep. 2 at 2:35 PM
$NVDA This is going to boom up $SER My new favorite stock THIS STOCK IS READY TO EXPLODE UP if your looking for some massive gains today $SER to the moon opportunity waiting for you . Your welcome!!!
0 · Reply
titotito25
titotito25 Aug. 29 at 7:11 PM
$SER
0 · Reply
StockBroker101
StockBroker101 Aug. 29 at 2:14 PM
$OPEN $OPAD $SER $SER dont miss out on this one
0 · Reply
StockBroker101
StockBroker101 Aug. 29 at 2:07 PM
$PMI Here we go baby! $SER check this one out
0 · Reply
BioTechHealthX
BioTechHealthX Aug. 29 at 1:57 AM
$SER Analysts see Serina stock surging as its unique POZ technology delivers long-acting therapies for neurological diseases with huge unmet need. https://biotechhealthx.com/biotech-news/wall-street-predicts-130-upside-for-serina-therapeutics-ser/
0 · Reply
wsb_kenny
wsb_kenny Aug. 28 at 7:13 PM
$SER it's time for run back to $8.8
1 · Reply
titotito25
titotito25 Aug. 28 at 6:57 PM
$SER volume low need wome volume to move up
0 · Reply
JarvisFlow
JarvisFlow Aug. 28 at 11:30 AM
HC Wainwright & Co. updates rating for Serina Therapeutics ( $SER ) to Buy, target set at 15.
0 · Reply
Bullliissh
Bullliissh Aug. 28 at 11:04 AM
$SER 6+ today 👀
0 · Reply
StockBroker101
StockBroker101 Aug. 28 at 10:53 AM
$SER
0 · Reply
IWILLMAKEYOUCRY
IWILLMAKEYOUCRY Aug. 28 at 8:34 AM
$SER 👀
0 · Reply
The_Colonel
The_Colonel Aug. 27 at 11:37 PM
$SER
0 · Reply
AARon12345
AARon12345 Aug. 27 at 5:25 PM
$SER volume dried up to nothing
1 · Reply
wsb_kenny
wsb_kenny Aug. 27 at 4:41 PM
$SER Parkinson's disease treatment market is going to be $7.58 billion. 40+ when drug gets approval.
0 · Reply
Bullliissh
Bullliissh Aug. 27 at 4:32 PM
$SER will finish green today!
0 · Reply
The_Colonel
The_Colonel Aug. 27 at 4:13 PM
$SER Back out. I thought it was going to quickly move much higher. A quick 8%.
0 · Reply
CometaMan
CometaMan Aug. 27 at 3:29 PM
$SER is getting noticed, That was a nice jump into the $7S a couple days ago. I would not be surprise to see this going into the $6S Nice swing for pennies, nickels and dimes, and o course quarters too! $INHD too
0 · Reply
Jackie_Treehorn
Jackie_Treehorn Aug. 27 at 3:17 PM
$SER in
0 · Reply
Ricofly123
Ricofly123 Aug. 27 at 2:20 PM
$SER hop in adap now
0 · Reply